- Brenntag’s Essentials operating gross profit was €696.1 million, falling short of the €712.5 million estimate.
- The Specialties segment posted an operating gross profit of €278.2 million, which missed the projected €292.7 million.
- Overall operating EBITDA stood at €246.4 million, below the anticipated €261.1 million.
- Within the Specialties division, operating EBITDA was reported at €98.8 million, not meeting the estimate of €111.5 million.
- Earnings per share (EPS) notably missed expectations, coming in at €0.30 compared to the estimated €0.93.
- Total sales amounted to €3.87 billion, which was below the forecasted €4.02 billion.
- Analyst recommendations include 7 buys, 10 holds, and 3 sells.
Brenntag AG on Smartkarma
Analyst Coverage of Brenntag AG on Smartkarma
Analysts at Baptista Research have initiated their coverage of Brenntag SE on Smartkarma, a platform where top independent analysts provide insights on various companies. In their report titled “Brenntag SE: Initiation of Coverage- Defying Inflation with Game-Changing Cost Discipline!“, the analysts highlighted the challenges faced by Brenntag SE, a major player in the chemical distribution industry. Despite reporting stable sales of EUR 4.1 billion in the first quarter of 2025, the company’s performance fell slightly short of expectations due to negative economic sentiments and a challenging industrial chemical pricing environment.
The analysts noted a 2% year-over-year increase in operating gross profit, reaching EUR 1.0 billion. However, factors such as economic uncertainty, volatile geopolitical conditions, and potential tariff impacts have created a tough business environment for Brenntag SE. The report showcases the company’s resilience in the face of inflationary pressures through game-changing cost discipline. The overall sentiment in the coverage leans towards a bullish outlook, emphasizing Brenntag SE’s ability to navigate through challenges and maintain its position in the industry.
A look at Brenntag AG Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 4 | |
| Growth | 4 | |
| Resilience | 3 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 3.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on Smartkarma Smart Scores, Brenntag AG shows a promising long-term outlook. With solid ratings in Dividend, Growth, and Resilience at 4, the company is positioned well to deliver returns to its shareholders while maintaining stable growth and weathering economic challenges. Although not the highest, its Value and Momentum scores at 3 indicate a balanced approach to pricing and market performance.
Brenntag AG, a company specializing in the sale and distribution of industrial and specialty chemicals, is expected to continue its positive trajectory in the market. With services ranging from chemical compound development to analysis, Brenntag serves various industries, including oil and gas, paint, cosmetic, pharmaceutical, and water treatment sectors. The company’s strong scores in Dividend, Growth, and Resilience reflect its capacity to generate steady income, support expansion, and withstand market fluctuations, positioning it as an attractive prospect for long-term investment.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
